000 | 01872 a2200529 4500 | ||
---|---|---|---|
005 | 20250517013224.0 | ||
264 | 0 | _c20150804 | |
008 | 201508s 0 0 eng d | ||
022 | _a1349-7006 | ||
024 | 7 |
_a10.1111/cas.12612 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYamaguchi, Takahiro | |
245 | 0 | 0 |
_aExpression of BAF57 in ovarian cancer cells and drug sensitivity. _h[electronic resource] |
260 |
_bCancer science _cApr 2015 |
||
300 |
_a359-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 1 |
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xbiosynthesis |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 |
_aChromosomal Proteins, Non-Histone _xbiosynthesis |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 |
_aDNA-Binding Proteins _xbiosynthesis |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 | _aRNA, Small Interfering |
700 | 1 | _aKurita, Tomoko | |
700 | 1 | _aNishio, Kazuto | |
700 | 1 | _aTsukada, Junichi | |
700 | 1 | _aHachisuga, Toru | |
700 | 1 | _aMorimoto, Yasuo | |
700 | 1 | _aIwai, Yoshiko | |
700 | 1 | _aIzumi, Hiroto | |
773 | 0 |
_tCancer science _gvol. 106 _gno. 4 _gp. 359-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cas.12612 _zAvailable from publisher's website |
999 |
_c24555985 _d24555985 |